Notice of Revision (Increase) to Consolidated Earnings Forecast and Dividend Forecast for the Fiscal Year Ending March 2027

Revision of Earnings Forecast and Causes

The consolidated earnings forecast for the fiscal year ending March 2027 is revised upward: net sales to 430,000 hundred million yen, operating income to 21,400 hundred million yen, ordinary income to 19,800 hundred million yen, net income attributable to owners of parent to 17,400 hundred million yen, and net income per share to 90 yen77 sen. Overall, solid sales and profit growth at the Takara Shuzo group contributed. Strong performance in overseas businesses and improvements in cost management were key drivers. Conversely, the Takara Bio group is expected to be affected by a global slowdown in the life sciences market and delays in new projects. Overall, performance is expected to exceed the previous forecast.

Revision of Dividend Forecast and Shareholder Returns

The annual dividend is revised to 34 yen. Both the interim and year-end dividends are set at 34 yen in total 34 yen. This policy change reflects the progressive dividend policy under the Takara Group Medium-Term Management Plan 2030 and the target total shareholder return ratio of 50% over five years. The revision follows the upward adjustment to earnings forecasts.